Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : COMS & the Ghost of USRX w/ other STUFF -- Ignore unavailable to you. Want to Upgrade?

To: Glenn D. Rudolph who wrote (10457)	12/10/1997 3:13:00 PM
From: Scrapps	Read Replies (3) \| Respond to of 22053

Glenn you're a bit late on that one......................... And the three or four post in reply which followed later. <GGG> Gotcha!!! :o) Message 2923482

To: Glenn D. Rudolph who wrote (10457)	12/10/1997 3:45:00 PM
From: Pullin-GS	Read Replies (2) \| Respond to of 22053

NEW YORK, Dec. 10 /PRNewswire/ -- Asensio & Company today issued the following: A study of 123 impotent men treated with Vivus' Muse product at the Centre for Impotence and Fertility in Rome, Italy found that Muse failed to make 121 of the penises rigid. This test's endpoint was very different than Vivus 1996 study, which used an "Erection Assessment Scale." The Italian study actually measured the rigidity of each penis and concluded that the penises were not hard. I wonder what they used to measure said organ with...a peter-meter perhaps?<VBG>